Back
Protalix BioTherapeutics Vs. Armata Pharmaceuticals Industry Stock Comparison
Buy
64
PLX
Protalix BioTherapeutics
Last Price:
1.15
Seasonality Move:
79.27%
Sell
29
ARMP
Armata Pharmaceuticals
Last Price:
2.19
Seasonality Move:
1.74%
Buy
64
Protalix BioTherapeutics (PLX)
is a Buy
Is Protalix BioTherapeutics a Buy, Sell or Hold?
- The current Protalix BioTherapeutics [PLX] share price is $1.15. The Score for PLX is 64, which is 28% above its historic median score of 50, and infers lower risk than normal.
- PLX is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
29
Armata Pharmaceuticals (ARMP)
is a Sell
Is Armata Pharmaceuticals a Buy, Sell or Hold?
- The current Armata Pharmaceuticals [ARMP] share price is $2.23. The Score for ARMP is 29, which is 42% below its historic median score of 50, and infers higher risk than normal.
- ARMP is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
PLX Stock Price Chart
What is Protalix BioTherapeutics's stock price today?
-
The Protalix BioTherapeutics share price today is $1.15
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and PLX is experiencing slight buying pressure.
ARMP Stock Price Chart
What is Armata Pharmaceuticals's stock price today?
-
The Armata Pharmaceuticals share price today is $2.23
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and ARMP is experiencing slight buying pressure.
PLX Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.02 | Buy |
| Relative Strength Index (14 RSI): | 66.12 | Buy |
| Chaikin Money Flow: | 55213 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | ( - ) | Buy |
| Bollinger Bands (100): | ( - ) | Buy |
ARMP Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.09 | Sell |
| Relative Strength Index (14 RSI): | 44.38 | Sell |
| Chaikin Money Flow: | 370 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (2.23 - 2.45) | Sell |
| Bollinger Bands (100): | (2.38 - 2.9) | Sell |
PLX Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 1.08 | Buy |
| 20-day SMA: | 1.01 | Buy |
| 50-day SMA: | 1.04 | Buy |
| 200-day SMA: | 1.29 | Sell |
| 8-day EMA: | 1.08 | Buy |
| 20-day EMA: | 1.04 | Buy |
| 50-day EMA: | 1.05 | Buy |
| 200-day EMA: | 1.25 | Sell |
ARMP Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 2.24 | Sell |
| 20-day SMA: | 2.34 | Sell |
| 50-day SMA: | 2.58 | Sell |
| 200-day SMA: | 2.99 | Sell |
| 8-day EMA: | 2.24 | Sell |
| 20-day EMA: | 2.32 | Sell |
| 50-day EMA: | 2.49 | Sell |
| 200-day EMA: | 2.75 | Sell |
Protalix BioTherapeutics Earnings Growth & PLX Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Armata Pharmaceuticals Earnings Growth & ARMP Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.06 per share, an increase next quarter of $0.13 per share, an increase this year of $0.01 per share, and an increase next year of $0.52 per share.
Protalix BioTherapeutics Technical Analysis
| Sep 6 | Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | Sep 16 | Sep 17 | Sep 18 | Sep 19 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep | ||||||||||
| 06 | 09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | 19 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Armata Pharmaceuticals Technical Analysis
| Sep 6 | Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | Sep 16 | Sep 17 | Sep 18 | Sep 19 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep | ||||||||||
| 06 | 09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | 19 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||